Gonorrhea Therapeutics Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the gonorrhea therapeutics market grown in recent years?
The market size for gonorrhea therapeutics has seen robust expansion over recent years. It is projected to escalate from $1.88 billion in 2024 to $1.98 billion in 2025, registering a compound annual growth rate (CAGR) of 5.4%. The surge during the historical period can be credited to factors such as the escalating resistance of Neisseria gonorrhoeae, the ascending prevalence of gonorrhea, a rise in antimicrobial resistance (AMR), a surge in antibiotic resistance, and the burgeoning use of dual therapy treatments.
How is the gonorrhea therapeutics market size expected to evolve during the forecast period?
The market size for gonorrhea therapeutics is predicted to observe robust growth in the coming years, reaching $2.42 billion by 2029 with a compounded annual growth rate (CAGR) of 5.2%. The growth in this period can be ascribed to the rise in sexually transmitted infections, an increased emphasis on personalized healthcare, escalating patterns of antibiotic resistance, a higher incidence rate of gonorracea, and a surging need for effective treatments. Major trends predicted to occur during this forecast period are technological advancements, sophisticated diagnostic tests, the creation of new therapeutics, the inception of combination therapies, and regulatory encouragement for accelerated drug approvals.
Get your gonorrhea therapeutics market report here!
https://www.thebusinessresearchcompany.com/report/gonorrhea-therapeutics-global-market-report
Which key drivers are propelling the gonorrhea therapeutics market’s growth?
The rise in sexually transmitted infection is anticipated to stimulate the expansion of the gonorrhea therapeutics market. Sexually transmitted infections (STIs), which can be transmitted by sexual contact, are triggered by bacteria, viruses, or parasites. The escalation in STIs can be attributed to factors such as unprotected intercourse, a lack of understanding or education, a rise in the number of sexual partners, a decrease in condom usage, and late or insufficient testing and treatment. Therapeutics for gonorrhea are utilized to combat sexually transmitted infections by targeting the neisseria gonorrhoeae bacteria to prevent potential complications and transmission. For example, a report released by the National Institute for Public Health and the Environment, located in the Netherlands, in June 2024 revealed that the count of gonorrhea cases diagnosed at sexual health clinics had a notable annual increase, inflating from 10,600 in 2022 to 13,853 in 2023, which represents a 31% increment. Thus, the escalating sexually transmitted infection is fueling the expansion of the gonorrhea therapeutics market.
What are the market segments in the gonorrhea therapeutics industry?
The gonorrhea therapeutics market covered in this report is segmented –
1) By Therapeutic Class: Antibiotics, Combination Therapy, Monotherapy
2) By Route Of Administration: Oral, Intravenous, Intramuscular
3) By Age Group: Pediatric, Adult, Geriatric
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Clinics, Home Care
Subsegments:
1) By Antibiotics: Beta-lactams, Macrolides, Fluoroquinolones, Aminoglycosides
2) By Combination Therapy: Dual Antibiotic Therapy, Triple Antibiotic Therapy
3) By Monotherapy: Single Antibiotic Treatment, Other Monotherapy Options
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21195&type=smp
Which leading companies are shaping the growth of the gonorrhea therapeutics market?
Major companies operating in the gonorrhea therapeutics market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, GlaxoSmithKline plc, Becton Dickinson and Company, Hologic Inc., Aurobindo Pharma Limited, Innoviva Inc., Debiopharm Group, Achilles Vaccines S.r.l., Melinta Therapeutics LLC, VenatoRx Pharmaceuticals Inc., Evofem Biosciences Inc., Recce Pharmaceuticals Ltd., Therapyx Inc., Entasis Therapeutics Inc., Apotex Inc., Alopexx Pharmaceuticals LLC, Summit Therapeutics Inc.
What emerging trends are influencing the growth of the gonorrhea therapeutics market?
Leading firms within the gonorrhea therapeutics market are pioneering new products, including rapidly acting polymerase chain reaction (PCR) exams, to allow for fast and precise identification of pathogens and their distinct features, such as resistance to antibiotics, during onsite care. A rapid PCR test is a diagnostic technique that quickly multiplies and identifies specific DNA or RNA sequences, facilitating swift identification of pathogens or genetic materials. For example, in February 2024, Visby Medical, Inc., an American medical tech firm, introduced a gonorrhea test complete with an antimicrobial resistance test. This speedy diagnostic test is built to identify Neisseria gonorrhoeae, the bacteria causing gonorrhea, and evaluate its vulnerability to ciprofloxacin, an antibiotic that some gonorrhea strains have become resistant to. This test is part of a transportable, instrument-less PCR framework, allowing for instant testing at the point of care. The test was subsidized by the non-profit organization CARB-X from the US, and Visby Medical, Inc., plans to grow this test to include detection of other sexually transmitted diseases, including Chlamydia trachomatis as well as Trichomonas vaginalis, in males.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21195
Which geographic areas are influencing the growth of the gonorrhea therapeutics market?
North America was the largest region in the gonorrhea therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gonorrhea therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Radiosurgery And Radiotherapy Robotics Global Market Report 2025
Dental Flap Surgery Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/dental-flap-surgery-global-market-report
Anti-Inflammatory Therapeutics Global Market Report 2025
https://thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
